Therapeutics: Akt: a double-edged sword

Nature Reviews Cancer

Volumn 9, Issue 2, 2009, Pages 76-77

  Swami, Meera ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYANIC ACID DERIVATIVE; ETOPOSIDE; PHENYLETHYLISOTHIOCYANATE; PROTEIN KINASE B; PROTEIN KINASE B BETA; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CELL AGING; CELL PROLIFERATION; DRUG POTENTIATION; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; NEOPLASM; NONHUMAN; OVARY CANCER; OXIDATIVE STRESS; PRIORITY JOURNAL; TUMOR CELL;

EID: 58849105010     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2586     Document Type: Article

References (1)

1. Nogueira, V. et al. Akt determines replicative senescence and oxidative or oncogenic premature sensescence and sensitizes cells to oxidative stress. Cancer Cell 14, 458-470 (2008)